Skip to content

Treatment of acne through tarunyapidikahar lepa.

Randomised clinical trial (RCT) on the effect of tarunyapidikahar lepa in management of tarunyapidika (Acne Vulgaris) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094994
Enrollment
40
Registered
2025-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

None listed

Sponsors

Dr Pooja Meena
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed patients with type of acne lesions like G0, G1, G2, and G3 (limited to face)

Exclusion criteria

Exclusion criteria: Age below 14 years and above 35 years. Complicated cases like cyst abscess etc. Acne with systemic involvement. (Eg: Acne fulminanes, SAPHO (Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis), PAPA (Pyogenic, Arthritis, Pyoderma gangrenosum, Acne) syndromes) Lesion present other than face.

Design outcomes

Primary

MeasureTime frame
Outcome of the therapies will be compared before and after the treatment on the basis of self formulated scoring scale to signs and symptoms in subjective and objective parameters. Relief in the following observing parameter- Pain- Ruja Itching -kandu Number of Acne lesion -sankhaya Oiliness of face Timepoint: 0th day, 30th day and 60th day

Secondary

MeasureTime frame
Improvement in quality of life Reduction in psychological stress, self-consciousness, and social embarrassment due to acne.Timepoint: 60th Day

Countries

India

Contacts

Public ContactDr Pooja Meena

Vaidya Yagya Dutt Sharma Ayurved Mahavidyalaya Associated Pt. PLRD Vaidya Chikitsalaya

vandanag54321@gmail.com8004675658

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026